To test the utility of the “A/T/N” system in the Chinese population, we study core Alzheimer’s disease (AD) biomarkers in a newly established Chinese cohort.
Early biomarkers are needed to identify patients at risk of developing postoperative cognitive dysfunction (POCD). Our objective was to determine neuronal injury-related biomarkers with predictive val
